Alström Syndrome (AS)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity (NCT03746522) | Rhythm Pharmaceuticals, Inc. | 2018-11-23 |
Track Alström Syndrome (AS) automatically
Every clearance here is in the API, with alerts when new ones post.